AVEO Pharmaceuticals to Present at IBC’s New Frontiers in Cancer Drug Development Conference

07/30/09
Back To Press & Events

 

Cambridge, MA - July 30, 2009 – AVEO Pharmaceuticals, Inc. today announced that Murray Robinson, Ph.D., senior vice president, oncology, is scheduled to present at IBC’s New Frontiers in Cancer Drug Development Conference on Tuesday, August 4, 2009 at 1:40 p.m. (EDT) at the World Trade Center Boston/Seaport Hotel in Boston, Mass.

 

Dr. Robinson will give a presentation titled “VEGF Pathway Response Biomarkers Using Population-based Preclinical Models” in a pre-conference workshop. This presentation will explore AVEO’s unique translational biology platform that queries entire populations of genetically engineered tumor models for drug response.

Share On Twitter Linkedin